High treatment persistence rate and significant endoscopic healing among real-life patients treated with vedolizumab - a Finnish Nationwide Inflammatory Bowel Disease Cohort Study (FINVEDO)

T Ylisaukko-Oja; J Aaltonen; H Nuutinen; A Jussila; K Hakala; M Lääne; H Sulonen

doi:10.1080/00365521.2017.1416160

High treatment persistence rate and significant endoscopic healing among real-life patients treated with vedolizumab - a Finnish Nationwide Inflammatory Bowel Disease Cohort Study (FINVEDO)

T Ylisaukko-Oja, J Aaltonen, H Nuutinen, A Jussila, K Hakala, M Lääne, H Sulonen

Research output: Contribution to journal › Article › Scientific › peer-review

24 Citations (Scopus)

Original language	English
Pages (from-to)	158-167
Journal	Scandinavian Journal of Gastroenterology
Volume	53
Issue number	2
DOIs	https://doi.org/10.1080/00365521.2017.1416160
Publication status	Published - 2018
Publication type	A1 Journal article-refereed

Publication forum classification

Publication forum level 1

Access to Document

10.1080/00365521.2017.1416160

Cite this

Ylisaukko-Oja, T., Aaltonen, J., Nuutinen, H., Jussila, A., Hakala, K., Lääne, M., & Sulonen, H. (2018). High treatment persistence rate and significant endoscopic healing among real-life patients treated with vedolizumab - a Finnish Nationwide Inflammatory Bowel Disease Cohort Study (FINVEDO). Scandinavian Journal of Gastroenterology, 53(2), 158-167. https://doi.org/10.1080/00365521.2017.1416160

@article{b8af39a4d0dd40dea3d2b6e776729913,

title = "High treatment persistence rate and significant endoscopic healing among real-life patients treated with vedolizumab - a Finnish Nationwide Inflammatory Bowel Disease Cohort Study (FINVEDO)",

author = "T Ylisaukko-Oja and J Aaltonen and H Nuutinen and A Jussila and K Hakala and M L{\"a}{\"a}ne and H Sulonen",

year = "2018",

doi = "10.1080/00365521.2017.1416160",

language = "English",

volume = "53",

pages = "158--167",

journal = "Scandinavian Journal of Gastroenterology",

issn = "0036-5521",

number = "2",

}

Ylisaukko-Oja, T, Aaltonen, J, Nuutinen, H, Jussila, A, Hakala, K, Lääne, M & Sulonen, H 2018, 'High treatment persistence rate and significant endoscopic healing among real-life patients treated with vedolizumab - a Finnish Nationwide Inflammatory Bowel Disease Cohort Study (FINVEDO)', Scandinavian Journal of Gastroenterology, vol. 53, no. 2, pp. 158-167. https://doi.org/10.1080/00365521.2017.1416160

High treatment persistence rate and significant endoscopic healing among real-life patients treated with vedolizumab - a Finnish Nationwide Inflammatory Bowel Disease Cohort Study (FINVEDO). / Ylisaukko-Oja, T; Aaltonen, J; Nuutinen, H et al.
In: Scandinavian Journal of Gastroenterology, Vol. 53, No. 2, 2018, p. 158-167.

Research output: Contribution to journal › Article › Scientific › peer-review

TY - JOUR

T1 - High treatment persistence rate and significant endoscopic healing among real-life patients treated with vedolizumab - a Finnish Nationwide Inflammatory Bowel Disease Cohort Study (FINVEDO)

AU - Ylisaukko-Oja, T

AU - Aaltonen, J

AU - Nuutinen, H

AU - Jussila, A

AU - Hakala, K

AU - Lääne, M

AU - Sulonen, H

PY - 2018

Y1 - 2018

U2 - 10.1080/00365521.2017.1416160

DO - 10.1080/00365521.2017.1416160

M3 - Article

SN - 0036-5521

VL - 53

SP - 158

EP - 167

JO - Scandinavian Journal of Gastroenterology

JF - Scandinavian Journal of Gastroenterology

IS - 2

ER -